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Abstract 28 
Dietary nitrate (NO3
-) supplementation via beetroot juice (BR) is known to 29 
improve endurance performance in untrained and moderately trained individuals. 30 
However, conflicting results exist in well-trained individuals. Evidence suggests 31 
that the effects of NO3
- are augmented during conditions of reduced oxygen 32 
availability (e.g., hypoxia), thereby increasing the probability of performance 33 
improvements for well-trained athletes in hypoxia vs. normoxia. This randomized, 34 
double-blinded, counterbalanced-crossover study examined the effects of 7 days 35 
of BR supplementation with 12.4 mmol NO3
- per day on 10-km cycling time trial 36 
(TT) performance in 12 well-trained cyclists in normoxia (N) and normobaric 37 
hypoxia (H). Linear mixed models for repeated measures revealed increases in 38 
plasma NO3
- and NO2
- after supplementation with BR (both p<0.001). Furthe , TT 39 
performance increased with BR supplementation (~1.6%, p<0.05), with no 40 
difference between normoxia and hypoxia (p=0.92). For respiratory variables 41 
there were significant effects of supplementation on VO2 (p<0.05) and VE 42 
(p<0.05) such that average VO2 and VE during the TT increased with BR, with no 43 
difference between normoxia and hypoxia (p≥0.86). We found no effect of 44 
supplementation on heart rate, oxygen saturation or muscle oxygenation during 45 
the TT. Our results provide new evidence that chronic high-dose NO3
- 46 
supplementation improves cycling performance of well-trained cyclists in both 47 
normoxia and hypoxia.        48 
                                                                                                           49 
Keywords: 50 
Nitrate,  51 
Nitrite,  52 
Endurance exercise,  53 
Cycling performance, 54 
Hypoxia, 55 
56 
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1.1 Introduction  57 
There is general consensus regarding the physiological factors that limit 58 
endurance performance [1,2]. These factors include maximal oxygen consumption 59 
(VO2max), the fractional utilization of VO2max, and exercise efficiency.  Even 60 
minor improvements in these factors can enhance performance of endurance 61 
athletes. One strategy proposed to improve performance is inorganic nitrate (NO3
-
62 
) supplementation, most often in the form of concentrated beetroot juice (BR) [3]. 63 
When ingested, nitrate is reduced to nitrite and nitric oxide (NO). This pathway 64 
differs from the classical pathway for NO generation which involves specific 65 
enzymes, NO-synthases (NOS) that use L-arginine and molecular oxygen to 66 
generate NO. Nitric oxide has been demonstrated to alter several physiological 67 
processes such as blood flow, mitochondrial functio and contractile properties 68 
[3-8]. Recently, several studies have provided evidnce that dietary intake of NO3
- 69 
can improve exercise efficiency (reduction in VO2 at same work rate) [9-12] and 70 
endurance performance [9,10,13-17]. Notably, the majority of studies reporting 71 
beneficial effects of NO3
- has been conducted in untrained and moderately trained 72 
individuals (VO2max < 60 ml/min/kg) [10,15,16,18], whereas studies in highly 73 
trained individuals (VO2max > 60 ml/min/kg) have shown minor [16,19-21] or no 74 
improvements [22-27], indicating that NO3
- may be less effective in this 75 
population [28,29]. In addition to this, recent studies in hypoxia have also 76 
provided evidence that NO3
- improves exercise efficiency [17,21,30,31], muscle 77 
oxygenation [31] and elevates oxygen saturation (SpO2) [21,30,31]. The lower O2 78 
availability in hypoxia impairs the L-Arginine-NOS pathway, and potentiates the 79 
nitrate-nitrite-NO pathway, suggesting that BR may be more effective in hypoxia 80 
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than in normoxia [3,32-34]. Supporting the notion that BR is more effective in 81 
hypoxia, Kelly et al. [30] showed that, in healthy individuals, BR improved time 82 
to exhaustion during severe intensity exercise in hypoxia but not in normoxia. In 83 
addition, BR has been shown to attenuate the decrease in muscle oxygenation and 84 
muscle metabolic perturbation in hypoxia in untrained and moderately trained 85 
subjects [31,35]. Hence, highly trained athletes may also experience greater 86 
performance improvements with BR in hypoxia compared with normoxia. 87 
Recently, few studies have examined this idea with conflicting results. In well-88 
trained athletes NO3
- supplementation had no effect on 10-km or 15-km cycling 89 
performance, 10-km running performance or roller-skiing treadmill performance 90 
in hypoxia [36-39]. Contrary to this, two studies have reported positive effects of 91 
BR in hypoxia on 16.1-km cycling performance and 1500m running performance 92 
in trained athletes [17,21]. The discrepancy could be due to different 93 
supplementation strategies for NO3
-. Specifically, the effects of NO3
- 94 
supplementation seems to be potentiated with BR as source of NO3
- [40,41], with 95 
chronic loading over several days [42,43], and by using a dose of >8mmol per day 96 
[13,20,44]. Optimizing the supplementation strategy of NO3
- may be even more 97 
important in trained athletes, as this population already exhibit adaptations elicited 98 
by endurance training and diet, including higher NO3
- plasma levels [45,46], NO 99 
release [47], NOS activity[48] and a higher percentage of type I fibers [8,49], that 100 
altogether may attenuate the response to NO3
- supplementation. 101 
The purpose of the present study was to examine the ffects of several days 102 
supplementation with a high-dose BR on cycling time trial performance in well-103 
trained cyclists, with continuous measurements of SpO2, muscle oxygenation and 104 
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oxygen uptake in normoxia and normobaric hypoxia. We hypothesized that BR 105 
would improve TT cycling performance in hypoxia but not in normoxia.  106 
2.1 Material and Methods 107 
2.1.1 Participants 108 
Twelve healthy male cyclists at the age of 29.1 ± 7.7 yrs (range 22 to 44 yrs) were 109 
enrolled in the study. Participants had a VO2max of 5.09 ± 0.47 L·min
-1 110 
corresponding to 66.4 ± 5.3 ml· in-1·kg-1 and a wattmax of 430 ± 35 watt 111 
corresponding to 5.6 ± 0.3 watt·kg-1 (mean ± SD). Participants were best classified 112 
as well-trained in performance level 4 as defined by Jeukendrup et al. [50] and De 113 
Pauw et al. [51], respectively. The protocol and test procedures used in the current 114 
study were conducted in accordance with the Declaration of Helsinki and 115 
approved by the Ethics Committee of Northern Jutland (N-20150049). All  116 
participants signed informed consent prior to enrollment.  117 
2.1.2 Study design 118 
Participants reported to the laboratory on five separate occasions. Experimental 119 
trials followed a randomized counterbalanced-crossover design and were double-120 
blinded for supplementation and single-blinded for inspiratory conditions. The 121 
first visit consisted of a maximal exercise performance test to ensure participants 122 
were familiar with testing procedures and to ensure participants met the inclusion 123 
criteria (i.e., VO2max > 60 ml·kg·min-1 or wattmax > 5 w/kg). Visits 2-5 involved 124 
four experimental trials (Fig 1). Each trial consisted of a 10-km time trial 125 
performed in conditions of normoxia or hypoxia, with supplementation of BR or 126 
nitrate-depleted BR as placebo (PLA). Specifically, supplementations were 127 
ingested in periods of seven days, separated by a wash out period of at least seven 128 
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days. During each supplementation period, 10-km time trials were performed on 129 
day four and day seven, in different conditions.  The order of condition was 130 
maintained for each individual for the first and second supplementation period 131 
such that visits 1 and 3 (and visit 2 and 4) were performed in the same condition. 132 
The design was counterbalanced for condition and supplementation such that half 133 
of the participants started with normoxia and half of the participants started with 134 
BR. All exercise trials were performed on the Cyclus2 ergometer (RBM Cyclus 2, 135 
Germany) using the participants’ own bike.  136 
Figure 1: Experimental design 137 
2.1.3 Maximal exercise performance  138 
Participants completed a 10-minute warm up at 100 watts and hereafter an 139 
incremental exercise test to exhaustion to determine gas exchange threshold 140 
(GET[30]), VO2max and wattmax (Fig 1).The incremental exercise test 141 
commenced at 100 watts and increased by 30 watts each minute until voluntary 142 
exhaustion. Following a 10-minute rest, participants completed a familiarization 143 
trial for the 10-km TT. While a VO2max validation bout is recommended [52], this 144 
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was not performed in this present study as these well-trained cyclists routinely 145 
achieve maximal effort during exercise. Respiratory breath-by-breath data were 146 
measured throughout the test using a metabolic cart (J eger, Vyntus CPX, 147 
Carefusion). The metabolic cart was calibrated before each test according to the 148 
manufacturer’s recommendations. Maximal oxygen uptake (VO2max) was 149 
determined as the highest 30-second average, Wattmax as peak power output from 150 
the last minute of the test ((watt) + time in last stage (s)/60 × 30 (W)) and heart 151 
rate (HR) as the peak value attained during the test. GET was determined from a 152 
number of measurements, including 1) the first disproportionate increase in VCO2 153 
from visual inspection of plotting VCO2 and VO2 and 2) an increase in expired 154 
ventilation (VE/VO2) with no increase in VE/VCO2 [30]. HR was recorded 155 
continuously using a heart rate sensor (Polar Electro, Oy, Finland).  156 
 157 
2.1.4 Experimental trials 158 
Participants ingested BR or PLA for seven consecutive days (Fig 1). Specifically, 159 
participants consumed 140ml of concentrated BR (~12.4 mmol nitrate) or 140ml 160 
of nitrate-depleted BR (PLA; ~0 mmol nitrate) (Beet It Sport, James White Drinks 161 
Ltd., Ipswich, UK) per day; one dose (70 ml) in themorning and one dose (70 ml) 162 
in the evening. On the days of the experimental tris (i.e., days four and seven), 163 
participants were instructed to consume the total dose (i.e., 140 ml) 2-h prior to 164 
arriving at the laboratory (approx. 2.75-h. before commencing the time trial). 165 
During the 24-h preceding the first experimental tri l, each participant recorded 166 
their diet and was told to replicate this diet for the remaining three trials. 167 
Participants were also instructed to avoid the intake of specific nitrate-rich foods. 168 
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The use of antibacterial mouthwash products was not permitted and caffeine 169 
intake was prohibited for 12-h preceding each test.For each individual, all 170 
experimental trials were performed at the same timeof day. 171 
Upon arrival at the laboratory, participants rested for 5-minutes before a resting 172 
blood sample was drawn into two 4 ml lithium heparin vacutainers 173 
(Becton Dickinson, Plymouth, UK). Blood samples were immediately centrifuged 174 
for 10 min at 4°C, 3000g after which plasma was extracted and stored at -80 ⁰C 175 
for later determination of plasma nitrate and nitrite according to the method 176 
described by Hezel et al. [53]. A near infrared spectroscopy (NIRS) probe 177 
(Oxymon MK III, Artinis Medical Systems, Netherlands) was placed on the belly 178 
of the Vastus Lateralis of the right leg in order to measure changes in muscle 179 
oxygenation. Probe position was marked with a permanent pen to ensure identical 180 
probe placement for subsequent trials, and the NIRS probe was placed with 181 
double-sided adhesive tape. Further, elastic bandages were used to ensure a fixed 182 
placement of the probe. An earlobe pulse oximeter (Nonin XPod 8000Q2, Nonin 183 
Medical, Inc, Plymouth, MN) was used to measure SpO2 throughout the tests. 184 
Participants then rested 5-minutes on the bike while breathing the gas mixture 185 
corresponding to the condition for that specific tral. Throughout each trial, 186 
participants breathed trough a facemask (Hans Rudolph, V-982185) connected to 187 
a low resistance y-valve (Hans Rudolph, two way Y-shape non-rebreathing valve, 188 
2730L), with the inspiration valve connected to a closed reservoir. The inspired 189 
gas was modified via the closed reservoir using a custom built setup consisting of 190 
a mechanical ventilator (SV-300, Maquet, Solna, Sweden) modified such that 191 
mixing of gas (pressurized room air and nitrogen) was controlled by manipulating 192 
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the inspired oxygen setting on the ventilator. The participants breathed through 193 
the same circuit for all experimental trials. The fraction of inspired oxygen was 194 
adjusted to 15 ± 0.1% in hypoxia (~2500m of altitude) and 20.9 ± 0.1% in 195 
normoxia (sea level). Warm-up consisted of three six-minute exercise bouts at the 196 
power output corresponding to 70% of GET measured in normoxia. A six-minute 197 
rest separated each bout. After the third bout, paricipants rested for 10 minutes 198 
without the facemask. Prior to the TT, participants sat on the bike for five minutes 199 
while breathing the gas mixture corresponding to the conditions for that specific 200 
trial. Then participants completed a 10-km TT with the instruction of finishing 201 
with the highest average power output and as fast as possible. Participants were 202 
blinded to all information except cadence and remaining distance of the TT, and 203 
were verbally encouraged at each km completed. VO2 and HR were measured 204 
continuously during the TT. For all physiological vriables, average values from 205 
the 10km-TT were calculated and used for further analyses.  Further, peak values 206 
for VO2, RER (both highest 30-s average) and HR (highest 1-s value) during the 207 
TT were calculated and used for further analyses.  The ratio of average power to 208 
average oxygen uptake (PO/VO2) during the time trial was used as an index of 209 
exercise efficiency [15]. NIRS variables of oxygenated (HbO2), deoxygenated 210 
(HHb) and total (THb) hemoglobin were recorded continuously at 2 Hz and 211 
expressed as relative changes (∆) from the baseline value measured during the 212 
final 90-seconds pre-exercise rest period.  213 
2.1.5 Statistical analysis 214 
Differences in performance and physiological parameters were analyzed using 215 
linear mixed models for repeated measures. This method of data analysis was 216 
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used as it has the advantage of preventing listwise del tion due to missing data 217 
(md). For clarification, md for each variable has been noted in table 1. As the 218 
dependent variable, the variable of interest was enter d (watt, VO2, VE, VCO2, 219 
SpO2, etc.) into the model. To investigate the effects of upplementation (BR vs. 220 
PLA), condition (hypoxia vs. normoxia) and supplementation-by-condition, these 221 
were entered as fixed effects. Subject id was included in the model as a random 222 
effect to control for the within-subject nature of the 4 trials. Further, paired t-tests 223 
were used to compare differences between the VO2peak obtained during the 224 
normoxic time trials and the VO2max from the ramp incremental test. Within group 225 
effect sizes were calculated as the difference in means (BR vs. PLA) divided by 226 
the pooled SD of the change score, using the following definitions: trivial effect d 227 
< 0.2, small effect > 0.2, moderate effect > 0.5, large effect > 0.8 [54]. 228 
Associations between changes in TT performance and changes in NO3
-, NO2
-, 229 
VO2, and SpO2 from PLA to BR were assessed using Pearson correlation 230 
coefficient. 231 
All data are presented as means ± SE, unless stated oth rwise, with statistical 232 
significance being accepted when P≤ 0.05. All statistical tests were performed 233 
using SPSS 25 (IBM Corp., Armonk, USA) or STATA (Texas, USA) version SE 234 
12.1.  235 
3.1 Results 236 
3.1.1 Plasma nitrate and nitrite  237 
There were significant main effects of supplementation on NO3
- and NO2
- (both 238 
p<0.001) such that BR elevated NO3
- and NO2
- (Fig 2). There were no effects of 239 
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condition (NO3
- p=0.858; NO2
- p=0.542) or supplementation-by-condition 240 
interaction (NO3
- p<0.907; NO2
- p=0.687).   241 
Further, there were no differences in levels of NO3
- (p=0.234) or NO2
- (p=0.231) 242 
between 4 and 7 days of supplementation (Fig 3).  243 
 244 
 245 
Figure 2: Individual and mean plasma levels of NO3
- (A) and NO2- (B) (mean±SE) prior to 246 
time trial tests in normoxia (open bars) and hypoxia (filled bars), after supplementation with 247 
beetroot juice (BR) or placebo (PLA). (#, p < 0.001, PLA vs. BR, N=11 in hypoxic 248 
conditions). 249 
 250 
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 251 
Figure 3: Individual and mean plasma levels of NO3
- (A) and NO2- (B) (mean±SE) prior to 252 
time trial tests at day 4 and day 7 after supplementation with beetroot juice (filled bars) or 253 
placebo (open bars). (#, p < 0.001, PLA vs. BR, N=11 in hypoxic conditions). 254 
 255 
3.1.2 Time trial performance 256 
All participants completed all four TT`s. However, two tests were discarded due 257 
to measurement error (n=1 in N-BR and n=1 in H-PLA). Time trial performance 258 
data are presented in Table 1. There was a main effect o  condition (p<0.001) on 259 
time trial performance such that hypoxia lowered power output by ~15%  and ~6 260 
%, respectively. Further, there was a main effect of supplementation on time trial 261 
power output (p=0.019) and completion time (p=0.024) showing an overall 1.6% 262 
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increase in power output  and 0.6% reduction in completion time with BR (Fig 4), 263 
with no condition-by-supplementation interaction (both p=0.923). Notably, 10 out 264 
of 11 participants increased power output in H-BR compared to H-PLA, whereas 265 
6 out of 11 increased power output in N-BR compared to N-PLA (Fig 4). Effect 266 
size calculations for within group differences betwen BR and PLA show 267 
moderate (0.703) and small (0.398) effects for hypoxia and normoxia, 268 
respectively.269 
 270 
Figure 4.  Individual and mean differences in power output (watt) during 10 km TT 271 
performance between placebo and beetroot supplementations in normoxic and hypoxic 272 
conditions. Bold horizontal lines indicate mean values for each condition. Single dotted line 273 
indicates no difference between beetroot and placebo supplementation   274 
 275 
 276 
 277 
 278 
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            Md  N-PLA N-BR H-PLA H-BR 
Linear mixed model effects 
Supplement Condition Interaction 
Time Trial    
Performance variable       
     Power output, Watt 2 311.3 ± 13.2 315.8 ± 13.2 64.4 ± 13.2 269.3 ± 13.2 p=0.019 p<0.001 p=0.923 
     Completion time, sec 2 890.1 ± 16 884.5 ± 16 945.6 ± 16 939.5 ± 16 p=0.024 p=0.001 p=0.923 
Average values       
     PO/VO2, W/ L
-1
·min-1 10 71.1 ± 1.8 70.8 ± 1.8 68.0 ± 1.8 68.0 ± 1.8 p=0.777 p=0.001 p=0.757 
     VO2, ml· min
-1 10 4364 ± 140 4443 ± 139 3855 ± 142 3948 ± 142 p=0.030 p<0.001 p=0.862 
     %VO2max 10 85.9 ± 1.6 87.4 ± 1.6 75.8 ± 1.7 77.7 ± 1.7 p=0.038 p<0.001 P=0.798 
     VCO2, ml· min
-1 10 4300 ± 151 4498 ± 150 4012 ± 153 4067 ± 153 p=0.005 p<0.001 P=0.120 
     VE, L· min-1 10 129.9 ± 7.0 135.8 ± 7.0 136.4 ± 7.1 142.4 ± 7.1 p=0.019 p=0.010 P=0.998 
     RER 10 0.99 ± 0.01 1.01 ± 0.01 1.04 ± 0.01 1.03 ± 0.01 p=0.462 p=0.003 P=0.082 
     HR· min-1,  3 168.5 ± 3.1 171.2 ± 3.1 169.4 ± 3.1 169.5 ± 3.1 p=0.118 p=0.486 P=0.072 
     SpO2, % 9 97.1 ± 0.9 97.1 ± 0.9 84.5 ± 0.9 84.3 ± 0.9 p=0.787 p=0.000 P=0.779 
Peak values         
     VO2peak, ml· min
-1 10 4925 ± 151 4895 ± 150 4225 ± 152 4304 ± 152 p=0.443 p<0.001  p=0.111 
     HRpeak,· min
-1 3 183.9 ± 2.9 185.5 ± 2.9 181.1 ± 2.9 181.5 ± 2.9 p=0.153 p<0.001 p=0.308 
     RERpeak 10 1.07 ± 0.02 1.1 ± 0.02 1.14 ± 0.02 1.14 ± 0.02 p=0.334 p=0.003 p=0.246 
NIRS         
     ∆HbO2, AU 3 -28.5 ± 2.6 -27.6 ± 2.6 -30.7 ± 2.6 -29.4 ± 2.6 p=0.543 p=0.061 p=0.849 
     ∆HHb, AU 3 24.5 ± 2.6 23.9 ± 2.6 26.3 ± 2.6 26.6 ± 2.6 p=0.885 p=0.042 p=0.633 
     ∆THb, AU 3 -4.3 ± 2.0 -3.4 ± 2.0 -3.9 ± 2.0 -2.7 ± 1.9 p=0.527 p=0.766  p=0.934 
     ∆HHb/VO2, AU· L·min
-1 12 5.68 ± 0.73 5.75 ± 0.71 7.01 ± 0.78 6.78 ± 0.74 p=0.851 p=0.017 p=0.728 
Table 1- Average and peak performance, ventilatory and cardiopulmonary data during the 279 
TT. md denotes the number of missing data points from each variable (complete number of 280 
data points = 48).  281 
3.1.3 TT physiological data 282 
Physiological data obtained during the TT are presented in Table 1. There were 283 
significant effects of condition on SpO2 (p<0.001), VE (p=0.010), RER 284 
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(p=0.003), VCO2 (p=0.001), VO2 (p<0.001), PO/VO2(p=0.001) and %VO2max 285 
(p<0.001) such that hypoxia decreased SpO2, VCO2, VO2, PO/VO2, VO2peak, 286 
HRpeak  and %VO2max while VE,RER and RERpeak increased. There were 287 
significant effects of supplementation on VO2 (p=0.030) (Fig 5), VE (p=0.019), 288 
VCO2 (p=0.005) and %VO2max (p=0.038) such that VO2, VE, VCO2 and %VO2max 289 
increased with BR. The VO2peak attained during the time trials in normoxia were 290 
significantly lower than the VO2max measured from the incremental test (N-PLA 291 
~3.3%, p=0.03; N-BR ~3.7%, p=0.02). 292 
 293 
 294 
 295 
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 296 
Figure 5- Oxygen uptake profiles from an exemplar subject (A) and mean data (B) from all 297 
conditions. 298 
 299 
3.1.4 Near infrared spectroscopy measures of muscle oxygenation  300 
Data reflecting changes in muscle oxygenation during the TT are presented in 301 
Table 1. There was a main effect of condition on ∆HHb (p=0.042) and 302 
∆HHb/VO2 (p=0.017) such that the increase in ∆HHb and ∆HHb/VO2 during the 303 
TT was greater in hypoxia (Table 1). We also found a near-significant main effect 304 
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of condition on ∆HbO2 (p=0.061) indicating a greater reduction of ∆HbO2 during 305 
TT in hypoxia.  306 
3.1.5 Correlations 307 
There were no significant correlations between changes in performance and 308 
changes in plasma NO3
- or NO2
- after BR supplementation in normoxia or 309 
hypoxia. Further, there were no significant correlations between changes in 310 
performance (BR vs. PLA) and changes in VO2 or SpO2 nor between changes in 311 
performance (BR vs. PLA) and VO2max. 312 
4.1 Discussion 313 
This is the first study to examine the effects of chronic supplementation with 314 
high-dose NO3
-, in the form of BR, on time trial performance in well-trained 315 
athletes in both hypoxia and normoxia.  316 
We show a significant main effect of BR on 10-km TT performance, indicating 317 
that well-trained cyclists improve power output and completion time with BR in 318 
both normoxia and hypoxia. Supplementation with BR also increased VO2 during 319 
the TT in hypoxia and normoxia, showing that the participants were able to utilize 320 
a higher fraction of VO2max with BR.  321 
4.1.1 Effects of BR supplementation on TT performance 322 
We found a main effect of BR supplementation on TT performance with no 323 
condition-by-supplementation interaction, indicating that BR increased TT 324 
performance with no difference between hypoxia and normoxia. However, from a 325 
practical perspective, it is worth highlighting that 10 out of 11 participants had 326 
higher power output in H-BR vs. H-PLA, while only 6 out of 11 had higher power 327 
output in N-BR vs. N-PLA (Figure 3). In support of a small effect of BR, a recent 328 
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meta-analysis, including studies performed in hypoxia and normoxia, reported a 329 
non-significant 0.8% improvement in time trial endurance performance following 330 
BR supplementation [55]. The  improvement in 10-km TT completion time and 331 
power output of 0.6% and 1.6%, respectively, in the present study, is of practical 332 
relevance for elite and well-trained athletes. Specifically, only 0.9% separated 333 
first and fourth position during the 13.8-km TT of stage 1 at the 2015 Tour De 334 
France cycling race [56], and only 0.3% separated th  first and third position 335 
during the 9.7-km TT of stage 1 at the 2018 Giro d´Italia cycling race [57]. 336 
Further, 0.6% is the smallest worthwhile change in completion time for road TT 337 
cyclists proposed by Paton and Hopkins [58].  338 
Few other studies have examined the effects of NO3
- on TT performance in well-339 
trained athletes in both normoxia and hypoxia within t e same study. None of 340 
these studies have reported significant improvements in TT performance after BR 341 
supplementation [36,38,39]. Nonetheless, the study by Bourdillion et al. [39] 342 
reported statistically non-significant improvements i  15-km TT performance of 343 
16s (~1%) and 151s (~7%) in normoxia and hypoxia, respectively.  344 
In general, studies on TT performance performed in well-trained athletes in 345 
hypoxia or in normoxia have reported mixed results. In hypoxia, two studies 346 
found statistically significant improvements of 2.2-3.2% (~2.2%) [17,21], while 347 
one study reported no effect [37]. In normoxia, numerous studies show no effect 348 
[22-27,59-61], while a few studies report a significant effect [15,16,20]. The 349 
discrepancy in the literature may partly be due to the use of different NO3
- 350 
supplementation strategies that vary in terms of source, dose, and duration (e.g., 351 
chronic vs. acute). Many of the previous TT studies have not used an optimized 352 
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supplementation strategy. Specifically, some studies have used sodium nitrate as 353 
the source of NO3
- [23,39], while there is evidence suggesting that 354 
supplementation with NO3
- in concentrated BR is more effective [40,62]. Several 355 
studies have used an acute dose of BR [17,25,26,36-38,59-61], however, a chronic 356 
loading protocol consisting of BR supplementation over several days, as used in 357 
the present study, has been suggested to be more effective in raising plasma levels 358 
of NO3
- and NO2
-, and improving performance [11,43]. Finally, several studies 359 
have used a low-to-moderate dose of NO3
- [36,37,59-61], while a higher dose (8-360 
16 mmol), as used in the present study, may be moreeffective in raising plasma 361 
levels and improving performance [13,20,44]. The high dose of NO3
- used in the 362 
present study was tolerated without any adverse events or complaints, 363 
demonstrating the efficacy of this supplementation strategy for 7 days. However, 364 
there is currently no evidence demonstrating additional benefits with doses higher 365 
than 8 mmol. In support of the notion that supplementation strategy is important, 366 
studies utilizing an optimized supplementation strategy with chronic 367 
supplementation of high dose NO3
- in the source of BR have reported a significant 368 
2.1% [16] and a non-significant 1.7% [24] improvement in TT power output in 369 
trained cyclists. 370 
4.1.2 Plasma levels of NO3
- and NO2
- 371 
In the present study, plasma levels of NO3
- and NO2
- after placebo (i.e., nitrate-372 
depleted BR) supplementation, were similar to results from other studies using 373 
nitrate-depleted BR [17,21,22,37,38,63]. 374 
Four and seven days of BR supplementation increased NO3
- and NO2
- to levels 375 
reported in studies using a similar supplementation strategy [13,22], with no 376 
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differences between 4 and 7 days. Notably, NO3
- and NO2
- levels, in the present 377 
study, were higher than those reported in studies using acute supplementation 378 
[17,21,37,38,63] ) or lower dosage of NO3
- [17,37,59,60]. Taken together, 379 
markedly elevated levels of NO3
- and NO2
-, in the present study, indicate that BR 380 
supplementation was effective in providing an abundant source of NO via the 381 
nitrate-nitrite-NO pathway. Plasma levels of nitrite displayed a higher variability 382 
compared to plasma nitrate (Fig 2 and Fig 3). This is a common finding and is 383 
most likely due to the shorter half-life of nitrite (l ss than 1h)[64] compared to 384 
nitrate (5-8h)[65]. This may be explained by a much higher reactivity of nitrite 385 
being subjected to both enzymatic reduction to NO and oxidation to nitrate [33]. 386 
Moreover, due to the markedly lower concentration of itrite in plasma, 387 
measuring techniques display more variable results compared to nitrate. 388 
4.1.3 Physiological effects of beetroot juice supplementation 389 
We found a main effect of supplementation on VO2, VE, VCO2 and %VO2max 390 
such that BR supplementation resulted in higher VO2, VE, VCO2 and %VO2max 391 
during the TT in both hypoxia and normoxia. As studies generally show 392 
unchanged [10,12,13,30] or reduced [66,67] VO2max following BR 393 
supplementation, these results indicate that the participants were able to utilize a 394 
higher proportion of their maximal aerobic capacity during the TT with BR. 395 
Further, in the present study, a proxy of exercise efficiency (PO/VO2) during the 396 
TT was unaffected by BR supplementation, suggesting that changes in exercise 397 
efficiency did not contribute to improved TT performance. In agreement with this, 398 
several studies, in well-trained athletes (>60 ml·min-1·kg-1), have shown 399 
unchanged exercise efficiency during submaximal exercis  following BR 400 
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supplementation [24,37,38,63], while only a single study has reported improved 401 
efficiency (lower VO2 during submaximal exercise) in well-trained athletes [21]. 402 
In club-level cyclists (56.0 ml·min-1·kg-1) [15], BR supplementation improved 403 
power output with unchanged VO2 (greater PO/VO2), indicating improved 404 
exercise efficiency. The discrepancy between these r ults could be due to the 405 
training level of the subjects, as our study included well-trained athletes (66.4 406 
ml·min-1·kg-1). Thus, the increase in %VO2max with BR was likely the main factor 407 
contributing to increased TT performance. In accordance with these results, 408 
Bourdillion et al. [39] reported greater VO2 and VE with nitrate supplementation 409 
in trained cyclists during a 15-km TT in normoxia and hypoxia, which was 410 
accompanied by a non-significant increase (1-7%) in performance (discussed 411 
above). Contributing to the increased VO2 with BR, the increase in VE (~6L/min) 412 
is estimated to account for 10-15 ml/O2 min (~10-20%) of the increase in VO2, 413 
due to greater oxygen demands of the respiratory muscles [68-70].  414 
The active skeletal muscles are the primary site for O2 usage during the TT, and 415 
oxygenation in the vastus lateralis was monitored continuously using NIRS. 416 
During the TT, ∆HHb increased in hypoxia compared with normoxia, indicating 417 
increased O2 extraction. However, in agreement with Kelly et al. [30] and 418 
Bourdillion et al. [39], ∆HHb was unaffected by BR supplementation, indicating 419 
that fractional O2 extraction in vastus lateralis was not different between BR and 420 
PLA. Hence, according to the Fick principle, the increased oxygen uptake in the 421 
present study may be a result of increased total O2 extraction due to increased 422 
blood flow. This interpretation is consistent with results demonstrating that NO3
- 423 
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supplementation enhances vascular control and muscle blood flow redistribution 424 
during exercise [8,49,72].  425 
5.1 Conclusion  426 
In summary, our results provide novel evidence that c ronic high-dose BR 427 
supplementation improves 10 km time trial performance of well-trained cyclists in 428 
both normoxia and hypoxia. Further, BR supplementation resulted in higher VO2 429 
and VE during the TT, suggesting that utilization of a greater proportion of the 430 
aerobic capacity contributed to the improved performance. While our results do 431 
not identify the underlying mechanisms, enhanced vascul r control and muscle 432 
blood flow redistribution may contribute to higher VO2 and improved time trial 433 
performance with BR supplementation. 434 
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• High-dose NO3
- supplementation improved time trial performance of cyclists  
• Oxygen uptake during the time trial was elevated with NO3
- supplementation  
• The effects of NO3
- supplementation were not different between hypoxia and normoxia 
 
 
